March 26, 2024 March 26, 2024Categories New TrialsNow Enrolling: ComboMATCH treatment trial E5 is testing a new option for patients with advanced solid tumors that have a KRAS G12C mutationThis study is assessing the combination of two drugs—sotorasib and panitumumab—in patients with KRAS G12C-mutated solid tumors
January 5, 2023 January 5, 2023Categories Ongoing TrialsOngoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancerThis trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
January 5, 2023 January 5, 2023Categories Ongoing TrialsOngoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancerThis trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
December 15, 2021 December 15, 2021Categories New TrialsNow Enrolling: The OPTIMUM clinical trial is studying an additional treatment for patients with multiple myelomaThis trial is for patients who have cancer cells still in the blood or bone marrow after approximately one year of lenalidomide maintenance therapy following a stem cell transplant